mental state grade 1 or 2 hepatic encephalopathy and hyperammonemia were randomly allocated to receive either Bifidobacterium and fructo-oligosaccharides or lactulose for 60 days. Psychometric ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

Lactulose is a medication used to treat hepatic encephalopathy, a complication of cirrhosis. It works on your digestive system to reduce levels of toxins like ammonia. If you have cirrhosis ...

Background and Aim: Development of overt hepatic encephalopathy (HE) is associated with poor prognosis in patients with cirrhosis. Lactulose is used for the treatment of HE. There is no study on ...

Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough ...

Minimal hepatic encephalopathy (MHE) affects 60–80% of patients with cirrhosis and is associated with poor quality of life, decreased work performance and impaired driving skills. Lactulose has ...

Get detailed information on Lactulose, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Normal protein for episodic hepatic encephalopathy: results of a randomized trial. J Hepatol 2004; 41: 38–43. CrossRef MEDLINE 3. Plauth M, Raible A, Graser TA, et al.: Lactulose or paromomycin ...

1. Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A: Pharmacotherapy for hepatic encephalopathy. Drugs 2010; 70: 1131–48. 2. Plauth M, Raible A, Graser TA, et al ...